FOLFOX与改良AIO化疗晚期肠癌的临床比较(2)
第1页 |
参见附件(360KB,3页)。
参考文献
[1] Seymour M T. Stenning S P. Cassidy J. et al. Attitudes and pratice in the management of metastatic colorectal cancer in Britain. Colorectal cancer working party of the UK medical research council[J]. Clin Onco,1997,9(4):24 8-251.
[2] 孙燕主编.大肠癌[M].内科肿瘤学,北京,人民出版社,2001,593~629.
[3] Schmoll HJ , Kohne CH, Lorenz M, et al. Weekly 24h infusion of high dose(HD) 5-fluorouracil(5- FU24h)with or without folinic acid(FA) vs. bolus 5- FU/FA(NCCTG/Mayo) in advanced colorectal cancer (CRC):A randomized phase III study of the EORTC GICCG and the AIO[J]. Proc Am Soc Clin Oncol, 2000,19:24la.
[4] 金从国,王熙才,伍治平等.癌症患者外周血T细胞亚群水平及床意义[J].肿瘤研究与临床,2003,15(1):33~34.
[5] Shar L Waldrop, Kenneth A Davis, Vernon C Maino et al. Normal human CD4 + memory T cell display broad heterogeneity in their activation threshold for cytokine synthesis. The Jourenal of Immunology, 1998; 161; 5284-5295.
[6] Y Nakamura, Y Tokuda, M I wasawa et al. Large- scale culture system of human CD4 + helper/killer T cell for the application to adoptive tumor immunotherapy. The British Journal of Cancer, 1992;66:20-26.
[7] Robert A Seder, Graham G Le Gros. The functional role of CD8+ T helper type 2 cells. The Journal of Experimental Medicine,1995;181:5-7.
[8] 赵志胜,王华.结直肠癌30例治疗前后外周血T淋巴细胞亚群变化及临床意义[J].南通医学院学报,1997,17(1):33~35.
注:“本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”
您现在查看是摘要介绍页,详见PDF附件(360KB,3页)。